Skip to main content
SpringerLink
Log in

Expression of ST3Gal, ST6Gal, ST6GalNAc and ST8Sia in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02

  • Original Article
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

We measured ST3Gal, ST6Gal, ST6GalNAc and ST8Sia expression in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02 to reveal the relationship between hepatic carcinoma cell lines sialyltransferases expression and cell membrane sialic acid sugar chains. Membrane sialic acid sugar chains in L-02, HepG-2 and SMMC-7721 cell lines were measured with lectin microarrays to find expression profiles. Expression of 20 sialyltransferases was measured with DNA microarray. qRT-PCR and Western blot were used to verify DNA microarrays data. Siaα 2-3Galβ1-3[Siaα2-6GalNAc]α-R and Siaα 2-6Gal/GalNAc sugar chains in hepatic carcinoma cell lines, HepG-2 and SMMC-7721 were upregulated, and 7differentially expressed sialyltransferases were captured. ST3Gal-IV and ST6Gal I were overexpressed and ST3Gal-I, ST3Gal-V, ST3Gal-VI, ST6GalNAcII and ST6GalNAcVI were downregulated in HepG-2 and SMMC-7721 cell Lines, compared with control cell line. ST6GalNAc-IV and ST8sia expressions were not detected. Other sialyltransferases were not different among cell lines. Results from qRT-PCR and Western blot were consistent with DNA microarray. Overexpression of ST3Gal-IV and ST6Gal I in HepG-2 and SMMC-7721 cell lines may correlate with upregulation of Siaα 2-3Galβ1-3[Siaα2-6GalNAc]α-R and Siaα 2-6Gal/GalNAc sugar chains on cell membranes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Deng, W., Li, R., Ladisch, S.: Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst 92(11), 912–917 (2000)

    Article  CAS  PubMed  Google Scholar 

  2. Schattenberg, J.M., Schuchmann, M., Galle, P.R.: Cell death and hepatocarcinogenesis: dysregulation of apoptosis signaling pathways. J Gastroenterol Hepatol 26(1), 213–219 (2011)

    Article  CAS  PubMed  Google Scholar 

  3. Miyagi, T., Wada, T., Yamaguchi, K., Hata, K.: Sialidase and malignancy: a minireview. Glycoconj J 20(3), 189–98 (2004)

    Article  CAS  PubMed  Google Scholar 

  4. Dall’Olio, F., Malagolini, N., Trinchera, M., et al.: Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression. Biochim Biophys Acta 9, 2752–64(2014) (1840)

    Google Scholar 

  5. Ma, R.H., Wang, D.Q., Pan, Z.C., et al.: Different expression of ST3Gal and ST6Gal mRNA between mouse hepatocellular carcinoma cell lines. Life Sci Res 15(4), 323–327 (2011)

    CAS  Google Scholar 

  6. He, Q., Li, C.H., Pan, Z.C., et al.: Glycoprofiling investigation of hepatocellular carcinoma cell surface with lectin microarray. Prog Biochem Biophys 37(3), 269–277 (2010)

    Article  Google Scholar 

  7. Guo, C., Liu, Q.G., Zhang, L., et al.: Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 8(4), 389–96 (2009)

    CAS  PubMed  Google Scholar 

  8. Lee, Y.C., Kurosawa, N., Hamamoto, T., et al.: Molecular cloning and expression of Galβ1, 3GalNAc α2, 3-sialyltransferase from mouse brain. Eur J Biochem 216(2), 377–385 (1993)

    Article  CAS  PubMed  Google Scholar 

  9. Kono, M., Ohyama, Y., Lee, Y.C., et al.: Mouse βgalactoside α2,3- sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 7(4), 469–479 (1997)

    Article  CAS  PubMed  Google Scholar 

  10. Kornfeld, S.: Diseases of abnormal protein glycosylation: an emerging area. J Clin Invest 101(7), 1293–1295 (1998)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Storey, E.L., Anderson, G.J., Mack, U., et al.: Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet 1(8545), 1292–4 (1987)

    Article  CAS  PubMed  Google Scholar 

  12. Ellies, L.G., Ditto, D., Levy, G.G., et al.: Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A 99(15), 10042–10047 (2002)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Hebert, D.N., Garman, S.C., Molinari, M.: The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrate as protein maturation and quality-control tags. Trends Cell Biol 15(14), 364–370 (2005)

    Article  CAS  PubMed  Google Scholar 

  14. Higai, K., Miyazaki, N., Azuma, Y., Matsumoto, K.: Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett 580(26), 6069–6075 (2006)

    Article  CAS  PubMed  Google Scholar 

  15. Chung, T.W., Kim, S.J., Choi, H.J., et al.: Ganglioside GM 3 inhibits VEGF/VEGFR-2-mediated angiogenesisDirect interaction of GM3 with VEGFR-2. Glycobiology 19(3), 229–239 (2009)

    Article  CAS  PubMed  Google Scholar 

  16. Adriane Regina, T., Jose Nilson Dos, S., Kazuko, H., et al.: Ganglioside GM2-Tetraspanin CD82 complex inhibits met and its cross-talk with integrins, control of cell motility through Glycosynapse. J Biol Chem 282(11), 8123–33 (2007)

    Article  Google Scholar 

  17. Paulson, J.C., Colley, K.J.: Glycosyltransferases structure localization and control of cell type-specific glycosylation. J Biol Chem 264(30), 17615–8 (1989)

    CAS  PubMed  Google Scholar 

  18. Souady, J., Hülsewig, M., Distler, U., et al.: Differences in CD75s-and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GalIand ST3GalVI in human hepatocellular carcinomas and nontumoral liver tissues. Glycobiology 21(5), 584–94 (2011)

    Article  CAS  PubMed  Google Scholar 

  19. Korekane, H., Matsumoto, A., Ota, F., et al.: Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate alpha2,6-sialylated blood group type 2H (ST2H)antigen. J Biochem 148(3), 359–370 (2010)

    Article  CAS  PubMed  Google Scholar 

  20. Paulson, J.C., Colley, K.J.: Glycosyltransferases structure localization and control of cell type-specific glycosylation. J Biol Chem 264(30), 17615–17618 (1989)

    CAS  PubMed  Google Scholar 

  21. Swindall, A.F., Bellis, S.L.: Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem 286(26), 22982–22990 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Milflores-Flores, L., Millán-Pérez, L., Santos-López, G., et al.: Characterization of P1 promoter activity of the beta-galactoside alpha 2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines. J Biosci 37(2), 259–267 (2012)

    Article  CAS  PubMed  Google Scholar 

  23. Dall’Olio, F., Chiricolo, M., D’Errico, A., et al.: Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology 14(1), 39–49 (2004)

    Article  PubMed  Google Scholar 

  24. Bouanene, H., Sahrawi, W., Mokni, M., et al.: Correlation between heterogeneous expression of Sialyltransferases and MUC16 in ovarian tumor tissues. Onkologie 34(4), 165–169 (2011)

    Article  CAS  PubMed  Google Scholar 

  25. Marcos, N.T., Pinho, S., Grandela, C., et al.: Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res 64(19), 7050–7057 (2004)

    Article  CAS  PubMed  Google Scholar 

  26. Senda, M., Ito, A., Tsuchida, A., et al.: Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAcVI in renal cancers. Biochem J 402(3), 459–470 (2007)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Sewell, R., Bäckström, M., Dalziel, M., et al.: The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. J Biol Chem 281(6), 3586–94 (2006)

    Article  CAS  PubMed  Google Scholar 

  28. Schneider, F., Kemmner, W., Haensch, W., et al.: Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 61(11), 4605–4611 (2001)

    CAS  PubMed  Google Scholar 

  29. Kroes, R.A., He, H., Emmett, M.R., et al.: Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo. Proc Natl Acad Sci U S A 107(28), 12646–12651 (2010)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Steenackers, A., Vanbeselaere, J., Cazet, A., et al.: Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase. Molecules 17(8), 9559–9572 (2012)

    Article  CAS  PubMed  Google Scholar 

  31. Dall’Olio, F., Malagolini, N., Trinchera, M., Chiricolo, M.: Sialosignaling:sialyltransferases as engines of self-fueling loops in cancer progression. Biochim Biophys Acta 9, 2752–2764(2014) (1840)

    Google Scholar 

Download references

Acknowledgments

We are grateful to Professor Qun He for her assistance in this work. This work was supported by a grant from the National Natural Science Foundation of China (awarded to Qun He, Grant No. 20672144). We thank LetPub (www.letpub.com) for their linguistic assistance during the preparation of this manuscript.

Conflict of interest statement

None declared

Funding

This work was supported by a grant from the National Natural Science Foundation of China (awarded to Qun He, Grant No. 20672144).

Author information

Authors and Affiliations

  1. Department of Biochemistry, College of Basic Medicine, Shenyang Medical College, Shenyang, 110034, Liaoning, China

    Yan Zhang

  2. Center of Laboratory Technology, China Medical University, Shenyang, 110001, Liaoning, China

    Wenjin Zhao

  3. Biochip Center, College of Basic Medicine, China Medical University, No.92, Beier Road, Shenyang, Liaoning Province, 110001, China

    Yan Zhang & Yujie Zhao

  4. Key Laboratory of Cell Biology,Ministry of Education, Basic Medical School, China Medical University, No.92, Beier Road, Shenyang, Liaoning Province, 110001, China

    Qun He

Authors
  1. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenjin Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yujie Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qun He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yujie Zhao or Qun He.

Additional information

This work was supported by a grant from the National Natural Science Foundation of China (awarded to Qun He, Grant No. 20672144).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Zhao, W., Zhao, Y. et al. Expression of ST3Gal, ST6Gal, ST6GalNAc and ST8Sia in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02. Glycoconj J 32, 39–47 (2015). https://doi.org/10.1007/s10719-014-9569-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-014-9569-z

Key words

Search

Navigation